Full Course Description

Cardiac Disease: Rehab Goals to Prevent Future Complications

Program Information

Target Audience

Athletic Trainers, Cardiovascular Technology Professionals, Nurses, Occupational Therapists & Occupational Therapy Assistants, Physical Therapists/Physical Therapist Assistants, Physician Assistants, and other Healthcare Professionals


  1. Determine the preferred treatment options based on acute heart disease pathophysiology.
  2. Investigate the diagnostic progression that could meet eligibility criteria for cardiac rehabilitation referral.
  3. Explore successful strategies for the most common lifestyle challenges that patients with acute cardiac disease may be experiencing.
  4. Analyze the effectiveness of secondary prevention programs.
  5. Evaluate gaps between in-patient and out-patient cardiac rehabilitation referrals.
  6. Separate LVAD, Life Vest and bridge therapies.
  7. Anticipate the next unexpected event when caring for heart disease patients.
  8. Assess opportunities to incorporate virtual technology use in patient monitoring and follow up.


Acute Heart Disease Diagnoses

  • Acute Coronary Syndrome
  • Acute Myocardial Infarction (STEMI and
  • Non-STEMI)
  • Angina
  • PTCA
  • CABG
  • Heart Transplant
  • Heart Failure
  • L VAD, Life Vest as Bridge or Destination
  • COPD
  • Diabetes


Cardiac Rehab Referrals

  • Who is eligible?
  • Educating in-patient nursing staff
  • Educating physicians
  • Computerized Medical Record use in triggering eligible patient populations
  • Patients who fall through the cracks


Lifestyle Challenges for Patients

  • Depression
  • Motivation
  • Compliance
  • Risk factors
  • Financial


Cardiac Rehab

  • Phases 1 - 4
  • Individualized treatment plans
  • Patient education
  • Monitoring quality outcomes
  • Evidence-based practice updates


Secondary Prevention Program

  • Becoming model for other programs
    • Hypertension
    • Obesity
    • Diabetes
    • Peripheral Vascular Disease


Effecting Change

  • Knowledge is not enough
  • Positive sense of self
  • Power of control
  • Readiness to change
  • Goals and independence
  • Feedback and celebrate success


Preparing for the Unexpected Event

  • Rapid response
  • Dysrhythmias
  • Syncope
  • Seizures
  • Cardiac arrest
  • Equipment, staffing


Insurance and Reimbursement

  • Medicare vs. private insurance
  • Number of sessions eligible
  • Billing and coding
  • Documentation


Preparing for Certification

  • When to start
  • Data collection
  • Role of Medical Director
  • Competencies


Heart Failure: Where are We at Incorporating Them into Rehab?


Use of Technology

  • Appointment reminders
  • Data reporting
  • Virtual technology for follow-up opportunities


Using Cardiac Rehab to Its Fullest

  • Partnering opportunities

Copyright : 12/06/2016

Advances in Diagnosis and Treatment of Neuromuscular & Neurodegenerative Disorders: What's Changed in 2016?

Program Information

Target Audience

Nurses, Occupational Therapists & Occupational Therapy Assistants, Physical Therapists/Physical Therapist Assistants, Physician Assistants, Speech-Language Pathologists


  1. Specify the preeminent medication management for multiple sclerosis and its complications.
  2. Breakdown the most recent diagnostic indicators for multiple sclerosis.
  3. Present your knowledge of Parkinson’s disease and its variants.
  4. Communicate common side effects to Parkinson’s medications.
  5. Analyze the pros and cons of medications vs. hands-on treatment for these diseases.
  6. Investigate the differences in myasthenic and cholinergic crisis.
  7. Explore the long-term care for muscular dystrophies.
  8. Formulate the syndrome variants for the patient with Guillain-Barré and CIDP.
  9. Investigate the symptom management for the patient with Amyotrophic Lateral Sclerosis.
  10. Explore newly found genomic markers for diagnosis and treatment of these disorders.


Multiple Sclerosis

  • 4 classifications
  • Risk factors: Low Vitamin D, abnormal lipid metabolism
  • Making the diagnosis 1-2-3
    • Neuromyelitis Optica, nystagmus
    • Genomic markers
  • MRI plain and 3-D
  • Treating multiple complications
  • Get Dancing and Get on a Bike exercises for MS
  • Medication updates 2016
  • Case Study

Parkinson’s Disease

  • Degeneration, Decline, and Autonomic Disease
    • A Prion Disease?
  • T-R-A-P symptoms
  • Non-motor complications
  • Biomarkers, LRRK variants
  • Medical treatment
    • Medications
    • Neuroprotection
  • Surgical treatment
    • Palidotomy, Thalamotomy, DBS, Stem cell transplantation
  • New PT/OT/SP guidelines for early engagement
    • Bikes, boxing, Big & Loud programs, forced exercise
    • Electrical stimulation
  • PD chameleons
    • Essential Tremor
    • Progressive supranuclear palsy
    • Corticobasilar degeneration
  • Case Study

Myasthenia Gravis

  • Neuromuscular Junction Disorder
    • Autoimmune
    • T-cell interference at NMJ
  • Edrophonium (Enlon™) Test for Diagnosis
    • MG vs. Lambert-Eaton
  • Short-acting anticholinesterase inhibitors
  • Thymectomy
  • Crisis: Myasthenic vs. Cholinergic
  • Emergent Treatment: Steroids, IVIG, Plasma
  • Exchange
  • Case Study

Muscular Dystrophy

  • Symptoms & causes
  • Complications over time
  • Treatment: Medical and surgical
  • Case Study

Guillain-Barré Syndrome

  • Syndrome of peripheral demyelination
    • Ascending
    • Pure motor
    • Descending
    • Miller-Fisher
  • Early diagnosis, earlier recovery
  • Causes: Viral, bacterial, surgical, vaccines, hyponatremia
  • Medical treatment: The Big 3 (steroids, IVIG, Plasmapheresis)
  • PT/OT/ST/Psych guidelines
  • Case Study

Chronic Inflammatory Demyelinating Polyneuropathy/radiculopathy

  • The elusive diagnosis dilemma
    • Symptoms, testing
  • Medical treatment for the short- and long-term
    • Living with neuropathic pain
    • Medication, spinal/brain stimulation
  • Best PT/OT guidelines
  • Case Study

Amyotrophic Lateral Sclerosis

  • Degeneration of the motor neurons
  • Genetic or generic disease?
    • Rule out everything else
  • Risk factors and neuroprotection
  • Medications help the complications
    • Alternative treatments
    • Stem cell research
  • Palliative considerations

Copyright : 10/18/2016